Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA4503 in acute ischemic stroke recovery
2007-004840-60Phase 2Completed
- Sponsor
- M's Science Corporation
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cutamesine in ischemic stroke (3 arms), sponsored by M's Science Corporation. Primary endpoints: Change in efficacy measures from baseline to Day 28 and Day 56, Neurological function by NIH Stroke Scale and 1 more. Started Oct 2007; status: completed.
02
Drugs
cutamesine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2007-004840-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004840-60.